Novel Variant in CLDN16: A Further Step in the Diagnosis of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis—A Case Report
Uro · 2021
DOI: 10.3390/uro1030011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Uro, 2021. Verfasst von Gopal Narang und 7 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare tubulopathy characterized by renal loss of calcium and magnesium leading to progressive renal failure. The disorder is caused by variants to the tight junction proteins claudin-16 and -19. While rare, this disorder causes a significant burden to patients based on its clinical manifestations of various electrolyte abnormalities, nephrocalcinosis, and early progression to renal failure. In this report we describe the diagnosis of a novel variant of CLDN16 which clinically presented with severe hypomagnesemia, hypocalcemia, nephrocalcinosis, and renal failure.
Zitieren
APA
Narang, G., Shimon, T., Moore, J., Hager, M., Vairo, F. P. E., Stern, K., Keddis, M., & Humphreys, M. (2021). Novel Variant in CLDN16: A Further Step in the Diagnosis of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis—A Case Report. Uro. https://doi.org/10.3390/uro1030011
Vancouver
Narang G, Shimon T, Moore J, Hager M, Vairo FPE, Stern K, et al. Novel Variant in CLDN16: A Further Step in the Diagnosis of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis—A Case Report. Uro. 2021. doi:10.3390/uro1030011
BibTeX
@article{Narang2021,
author = {Narang, Gopal and Shimon, Tim and Moore, Jonathan and Hager, Megan and Vairo, Filippo Pinto e and Stern, Karen and Keddis, Mira and Humphreys, Mitchell},
title = {Novel Variant in CLDN16: A Further Step in the Diagnosis of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis—A Case Report},
journal = {Uro},
year = {2021},
doi = {10.3390/uro1030011}
}
EUVIMED